Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Rediscovery Life Sciences logo — Developing safer medicines through innovative drug repurposi...

Rediscovery Life Sciences

Developing safer medicines through innovative drug repurposing.

Founded 2016 United States Cambridge, United States 3 employees Series B Total: $9.80M Biopharma, Pharmaceutical

General Information

Company Name Rediscovery Life Sciences
Founded Year 2016
Location United States Cambridge, United States
Employees 3
Industries Biopharma, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Rediscovery Life Sciences. To contact Rediscovery Life Sciences, visit rediscoveryls.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rediscovery Life Sciences compare?

A PDF of Rediscovery Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rediscovery Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Rediscovery Life Sciences

Rediscovery Life Sciences, with the slogan “Developing safer medicines through innovative drug repurposing,” is a biopharmaceutical company founded in 2016. Headquartered in the United States, the company focuses on developing proprietary therapeutics by repurposing existing drugs, aiming to reduce both time and financial risk in identifying effective treatments.

Operating within the Biopharma and Pharmaceutical industries, Rediscovery Life Sciences leverages its innovative approach to offer a compelling value proposition. Notable investors, such as Rex Health Ventures and Orlando Health Ventures, participated in their last funding round, a $4.50M Series B investment on 01 September 2020.

By minimizing development risks, Rediscovery Life Sciences potentially accelerates time-to-market for new therapies, presenting an attractive opportunity for investment aimed at innovating in drug development and healthcare solutions.

Business keywords: biopharma, drug repurposing, medicine development, pharmaceuticals, innovation, acute kidney injury, drug discovery, risk reduction, medical research

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $4.50M 2
Rex Health Ventures Orlando Health Ventures
Rex Health Ventures, Orlando Health Ventures
01 Sep 2020
Series B $3.80M -
01 Apr 2020
Seed $1.50M -
01 Aug 2016
Spinout Undisclosed 1
Medical University of South Carolina
01 Jan 2014

Rediscovery Life Sciences Alternatives & Competitors

View All Alternatives
Rediscovery Life Sciences vs
Abzena
Abzena United States

Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly movin...

Private Equity
436 employees
Biopharma, Biotechnology
Rediscovery Life Sciences vs
Lipidio Pharmaceuticals
Lipidio Pharmaceuticals United States

Transforming Molecules into the Right Medicines

4 employees
Biopharma, Biotechnology
Rediscovery Life Sciences vs
Celadon Pharmaceuticals
Celadon Pharmaceuticals United Kingdom

UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannabis-based m...

IPO
18 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Rediscovery Life Sciences

Developing safer medicines through innovative drug repurposing.
Rediscovery Life Sciences was founded in 2016.
Rediscovery Life Sciences is headquartered in Cambridge, United States.
Rediscovery Life Sciences operates in Biopharma and Pharmaceutical. Its work centres on biopharma, drug repurposing, medicine development and pharmaceuticals.
Rediscovery Life Sciences has approximately 3 employees.
Rediscovery Life Sciences has completed 4 funding rounds, raising a total of $9.80M. The latest funding stage is Series B.
Top alternatives and competitors to Rediscovery Life Sciences include Abzena, Lipidio Pharmaceuticals , Celadon Pharmaceuticals, IXALTIS SA, MOLCURE Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rediscovery Life Sciences and Abzena are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rediscovery Life Sciences, https://bouncewatch.com/company/rediscovery-life-sciences, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes